HIV treatment study with ibalizumab and chidamide
Part of Immune system & allergy, Infections clinical trials.
This study tests whether combining two drugs, ibalizumab and chidamide, can reduce the hidden HIV in your body. It aims to see if this combination is safe and might help control HIV better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have confirmed HIV infection.
- You have been on the same HIV medications for at least 6 months.
- Your viral load is undetectable.
- Your CD4 count is above 200.
- You are willing to use effective birth control during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combination of a drug (chidamide) and specially engineered immune cells (NKG2D CAR-NK cells) to try to reduce the hidden HIV in your body. It may help you if you are on effective HIV treatment and your viral load is undetectable.
This study tests whether combining two or more investigational drugs that can activate the hidden HIV reservoir in your body might help eliminate it. The goal is to see if this approach is safe and could help lead to a cure for HIV.
This trial tests whether combining immune-boosting drugs with chidamide (a medication that may wake up hidden HIV) can help your body control HIV without daily antiretroviral therapy. It aims to achieve a 'functional cure,' meaning the virus stays suppressed even after stopping regular HIV meds.
This study tests a new combination of two drugs to see if they can reduce the 'hidden' HIV that stays in your body even when you're on regular HIV treatment. The goal is to work toward a cure, not just control.
This study tests whether a combination of two lab-made antibodies plus an immunotherapy drug can help control HIV without daily antiretroviral pills. If successful, it might allow a safe break from your current HIV medications while keeping the virus under control.
This study tests whether giving two experimental drugs together can help your immune system find and destroy hidden HIV cells. It aims to see if this approach can reduce the amount of virus in your body even while you're on your regular HIV medications.
Hear when a new HIV (Human Immunodeficiency Virus) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.